Cllnidipine in Treatment of Patients with Mild to Moderate Primary Hypertension
Lijuan Zhou
Abstract
Lijuan Zhou
Abstract
Objective:To assess the effects of cilnidipine in the treatment of patients with mild to moderate primary hypertension.Methods:Forty-three patients with mild to moderate primary hypertension received double_blind,crossover trail with cilnidipine or amlodipine for8weeks,and the changes of blood pressure,heart rate and blood biochemical value were observed.Results:The blood pressure reduced to normal level at the end of8weeks after the treatment.Blood FBG,TC,TG,HDL,K + ,Na + and Cr had no significant difference at the end of8weeks of the treatment compared with those before the treatment.Conclusion:Cilnidipine can treat patients with mild to moderate primary hypertension effectively,safely.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To assess the effects of cilnidipine in the treatment of patients with mild to moderate primary hypertension.Methods:Forty-three patients with mild to moderate primary hypertension received double_blind,crossover trail with cilnidipine or amlodipine for8weeks,and the changes of blood pressure,heart rate and blood biochemical value were observed.Results:The blood pressure reduced to normal level at the end of8weeks after the treatment.Blood FBG,TC,TG,HDL,K + ,Na + and Cr had no significant difference at the end of8weeks of the treatment compared with those before the treatment.Conclusion:Cilnidipine can treat patients with mild to moderate primary hypertension effectively,safely.
Key concepts: Medicine, Amlodipine, Blood pressure, Internal medicine, Significant difference, Crossover study, Cardiology, Pathology